Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81
Document › Details

Homburger AG. (12/4/15). "News: Kuros Biosurgery Holding and Cytos Biotechnology Announce Combination to Create Kuros Biosciences".

Region Region Switzerland
Organisations Organisation Homburger AG
  Organisation 2 Kuros Biosurgery AG
  Group Kuros (Group)
Products Product legal services
  Product 2 tissue engineering / regenerative medicine
Index terms Index term Kuros–Homburger: legal services, 201512 supply service legal advisor w regard to reverse merger acquisition CHF160m of Kuros Biosurgery by Cytos
  Index term 2 Kuros–Cytos Biotechnology: investment, 201512–201601 reverse merger acquisition CHF160m of Kuros Biosurgery by Cytos to be renamed Kuros Biosciences
Person Person Gericke, Dieter (Homburger 201512 Partner Corporate & M&A)

On December 3, 2015, Cytos Biotechnology AG (SIX: CYTN) (Cytos) and Kuros Biosurgery Holding AG (Kuros) announced their agreement to combine their businesses. The transaction is structured as a reverse merger in which Kuros' shareholders exchange their Kuros shares for new Cytos shares, subject to shareholder approval and other conditions. Following the closing, the current shareholders of Cytos will own approximately one-fifth and Kuros' shareholders will hold approximately four-fifths of the issued shares of Cytos, which will be renamed "Kuros Biosciences AG" and will continue to be listed on the SIX Swiss Exchange. Kuros will become a subsidiary of Kuros Biosciences AG. The aggregate value of the consideration shares as per the Cytos share price on the day of announcement is approx. CHF 160 million.

Kuros is a Zurich-based privately held company focused on the development of products for tissue repair and regeneration. Cytos is a biopharmaceutical company based in Schlieren (Zurich), Switzerland. Kuros Biosciences AG will be led by the existing Kuros executive management team. The board of directors of Kuros Biosciences AG will comprise directors or officers of both Kuros and Cytos.

Kuros is advised by Homburger in this transaction. The Homburger team is led by partner Dieter Gericke (Corporate | M&A) and includes partner Reto Heuberger (Tax), associates Sergio Bortolani and Daniel Häusermann (both Corporate | M&A) and Pascal Meier (Litigation | Arbitration) as well as junior associate Nicolas Jauslin (Corporate | M&A).

Record changed: 2017-04-02


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Homburger AG

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

» top